Skip to main content
SpringerLink
Log in

Glucosamine and Chondroitin

  • Chapter
Dietary Supplements

Part of the book series: Forensic Science and Medicine ((FSM))

  • 343 Accesses

Abstract

In the 1950s, in vitro studies of glucosamine demonstrated its potential to increase fibroblast production of collagen and mucopolysaccharides. These findings led to studies of glucosamine for the treatment of osteoarthritis (OA) in humans, first with an injectable product, and then with oral supplementation (McCarty, 1994). Public interest in the use of glucosamine for OA increased in the late 1990s, in some measure owing to the publication of two books for laypersons on the subject, The Arthritis Cure and Maximizing the Arthritis Cure (Thie et al., 2001).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Almada AL, Harvey PW, Platt KJ. Effect of chronic oral glucosamine sulfate upon fasting insulin resistance index (FIRI) in nondiabetic individuals [abstract]. FASEB J 2000; 14: A750.

    Google Scholar 

  • American Nutraceutical Association. Dietary supplements containing glucosamine and chondroitin sulfate found in University of Maryland College of Pharmacy study to contain significantly less ingredients when compared with label claims. Available at: http://www.ana.jana.org/press.html. Accessed July 24, 2000.

  • Anonymous. Osteo-Bi-Flex success reflects traditional consumer branding approach. Dietary Suppl Market Review. August, 1999. p. 1.

    Google Scholar 

  • Anonymous. Supplements. Pharmacists Let 2001a; 17: 65.

    Google Scholar 

  • Anonymous. Pharmacy Fax Monitor. Totowa, NJ:Healthcare News Monitor Inc. December 16, 2001b.

    Google Scholar 

  • Anonymous. Questions and answers: NIH study on glucosamine/chondroitin sulfate for knee osteoarthritis. Available from: URL: http://www.altmed.odnih.gov/nccam/ne/press-releases/gcs-facts.html. Accessed May 26, 2000.

  • Ascione FJ, Manifold CC, Parenti MA. Principles of drug information and scientific literature evaluation. Hamilton, IL: Drug Intelligence Publications, 1994.

    Google Scholar 

  • Balkan B, Dunning BE. Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 1994; 43: 1173–9.

    Article  PubMed  CAS  Google Scholar 

  • Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 1998; 6: 427–34.

    Article  PubMed  CAS  Google Scholar 

  • Bodewes J. Glucosamine and chondroitin. Drs. Foaster and Smith, Inc. Veterinary Services Department. Available from: URL: http://peteducation.com/nutrition/glu_chond.htm. Accessed May 8, 2000.

  • Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of chondroitin sulfate 1200 mg/ day vs chondroitin sulfate 3 x 400 mg/day vs placebo. Osteoarthritis Cartilage 1998; 6 (suppl A): 25–30.

    Article  PubMed  Google Scholar 

  • Briggs GG. Teratogenicity and drug in breast milk. In: Young LY, Koda-Kimble MA, eds. Applied therapeutics; the clinical use of drugs. 6th edition. Vancouver, WA: Applied Therapeutics 1995; p. 45. 1–39.

    Google Scholar 

  • Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 1998; 6 (suppl A): 31–6.

    Article  PubMed  Google Scholar 

  • Campo GM, Campo S, Ferlazzo AM, Vinci R, Calatroni A. Improved high-performance liquid chromatographic method to estimate aminosugars and its application to glycosaminoglycan determination in plasma and serum. J Chromatogr B Biomed Sci Appl 2001; 765: 151–60.

    Article  PubMed  CAS  Google Scholar 

  • Canapp SO, McLaughlin RM, Hoskinson JJ, Roush JK, Butine MD. Scintigraphic evaluation of dogs with acute synovitis after treatment with glucosamine hydrochloride and chondroitin sulfate. Am J Vet Res 1999; 60: 1552–7.

    PubMed  CAS  Google Scholar 

  • Conn DL, Arnold WJ, Hollister JR. Alternative treatments and rheumatic diseases. Bull Rheum Dis 1999; 48: 4.

    Google Scholar 

  • ConsumerLab.com. News. Consumerlab.com finds many arthritis supplements lacking labeled ingredient. Glucosamine and chondroitin product review published today. Available at: http://www.consumerlabs.com/news/news_3700.html. Accessed September 26, 2000.

  • Conte A, de Bernardi M, Palmieri L, et al. Metabolic fate of exogenous chondroitin sulfate in man. Arzneimittelforschung 1991; 41: 768–72.

    PubMed  CAS  Google Scholar 

  • Conte A, Volpi N, Palmieri L, Bahous I, Ronca G. Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Arzneimittelforschung 1995; 45: 918–25.

    PubMed  CAS  Google Scholar 

  • Crolle G, D’Este E. Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation, Curr Med Res Opin 1980; 7: 104–9.

    Article  PubMed  CAS  Google Scholar 

  • D’Ambrosio E, Casa B, Bompani R, Scali M. Glucosamine sulfate: a controlled clinical investigation in arthrosis. Pharmacotherapeutica 1981; 2: 504–8.

    Google Scholar 

  • Das A, Hammad TA. Efficacy of a combination of FCHG49TM glucosamine hydrochloride, TRH122TM low molecular weight chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 2000; 8: 343–50.

    Article  PubMed  Google Scholar 

  • Donohoe M. Efficacy of glucosamine and chondroitin for treatment of osteoarthritis [letter]. JAMA 2000; 284: 1241.

    Article  PubMed  CAS  Google Scholar 

  • Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine sulfate in osteoarthritis: a placebo-controlled double-blind investigation. Clin Ther 1980: 3: 260–72.

    PubMed  CAS  Google Scholar 

  • F-D-C reports. Five of 32 chondroitin products tested met label claims—JANA study. The Tan Sheet 2000; 8: 19.

    Google Scholar 

  • Horstman J, Wood C. Glucosamine and chondroitin. Arthritis Today 1998; 12: 46–9.

    Google Scholar 

  • Houpt JB, McMillan R, Wein C, Paget-Dellio SD. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 1999; 26: 2423–30.

    PubMed  CAS  Google Scholar 

  • Hughes RA, Chertsey AJC. A randomized, double-blind, placebo-controlled trial of glucosamine to control pain in osteoarthritis of the knee [abstract]. Arthritis Rheum 2000; 9 (suppl): S384.

    Google Scholar 

  • Kier KL. Clinical application of statistical analysis. In: Malone PM, Mosdell KW, Kier KL, Stanovich JE, eds. Drug information. A guide for pharmacists. Stamford, CT: Appleton and Lange; 1996.

    Google Scholar 

  • Leeb BF, Schweitzer H, Montag K, Smolen JS. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2000; 27: 205–11.

    PubMed  CAS  Google Scholar 

  • Leffler CT, Philippi AF, Leffler SG, Mosure JC, Kim PD. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med 1999; 164: 85–91.

    PubMed  CAS  Google Scholar 

  • Liang Z, Leslie J, Adebowale A, Ashraf M, Eddington ND. Determination of the nutraceutical, glucosamine hydrochloride, in raw materials, dosage forms, and plasma using pre-column derivitization with ultraviolet HPLC. J Pharmaceut Biomed Anal 1999; 20: 807–14.

    Article  CAS  Google Scholar 

  • March LM. Osteoarthritis. Med J Aust 1997; 166: 98–103.

    PubMed  CAS  Google Scholar 

  • Matheu V, Garcia Bara MT, Pelta R, Vivas E, Rubio M. Immediate-hypersensitivity reaction to glucosamine sulfate. Allergy 1999; 54: 643–50.

    Article  PubMed  CAS  Google Scholar 

  • McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis. A systematic quality assessment and meta-analysis. JAMA 2000; 283: 1469–75.

    CAS  Google Scholar 

  • McCarty MF. The neglect of glucosamine as a treatment for osteoarthritis—a personal perspective. Med Hypotheses 1994; 42: 323–7.

    Article  PubMed  CAS  Google Scholar 

  • Morreale P, Manopulo R, Galati M, et al. Comparison of the anti-inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 1996; 23: 1385–91.

    PubMed  CAS  Google Scholar 

  • Mosdell KW. Literature evaluation. In: Drug information: a guide for pharmacists. Stamford, CT: Appleton and Lange; 1996; p. 89–119.

    Google Scholar 

  • Müller-Faßbender H, Bach GL, Haase W, Rovati LC, Setnikar I. Glucosamine sulfate compared with ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 1994; 2: 61–9.

    Article  PubMed  Google Scholar 

  • Noack W, Fischer M, Förster KK, Rovati LC, Setnikar I. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 1994; 2: 51–9.

    Article  PubMed  CAS  Google Scholar 

  • Nutramax Laboratories, Inc. Cosequin®, Coseqin DS®. Available from: URL:http://www.cosamin.com/veterinary/products/cosequins.htm. Accesssed May 26, 2000a.

  • Nutramax Laboratories, Inc. Cosamin® DS FAQ. Available from:URL:http://www.cosamin.com/human/cosaminfaq.htm. Accessed May 25, 2000b.

  • Nutramax Laboratories, Inc.. Cosequin® equine powder concentrate. Available from: URL:http://www.cosamin.com/veterinary/products/cosequine.htm. Accessed May 26, 2000c.

  • Nutramax Laboratories, Inc. Double Strength Cosamin® DS. Available from: URL:http://www.cosamin.com/human/cosamin.htm. Accessed May 13, 2000d.

  • Nutrasense M Company. Glucosamine FAQ’s. Available from: URL: http://www.nutrasense.com/glucfagl.html. Accessed May 8, 2000e.

  • Pavelka K, Gatterova J, Olejarova M, et al. Glucosamine sulfate decreases progression of knee osteoarthritis in a long-term, randomized, placebo-controlled independent, confirmatory trial [abstract]. Arthritis Rheum 2000; 9 (suppl): S384.

    Google Scholar 

  • Pinals RS. Mechanisms of joint destruction, pain and disability in osteoarthritis. Drugs 1996; 52 (suppl 3): 14–20.

    Article  PubMed  CAS  Google Scholar 

  • PhytoPharmica. Company news. Phytopharmica is the first to receive consumerlab.com seal of approval for glucosamine sulfate. Available from: URL: http://www.phytopharmica.com/consumer/new/conews.html. Accessed September 26, 2000.

  • Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthritis. Curr Med Res Opin 1980; 7: 110–4.

    Article  PubMed  CAS  Google Scholar 

  • Qiu GX, Gao SN, Giacovelli G, Rovati L, Setnikar I. Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. Arzneimittelforschung 1998; 48: 469–74.

    PubMed  CAS  Google Scholar 

  • Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 357: 251–6.

    Article  PubMed  CAS  Google Scholar 

  • Reichelt A, Forster KK, Fischer M, Rovati L, Setnikar I. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. Arzneim Forsch Drug Res 1994; 44: 75–80.

    CAS  Google Scholar 

  • Rexall Sundown. Osteo Bi-Flex® glucosamine chondroitin. Frequently asked questions. Available from: URL: http://www.osteobiflex.com/pages/faq.htm. Accessed May 8, 2000a.

  • Rexall Sundown. Osteo Bi-Flex® glucosamine chondroitin. Available from: http://www.osteobiflex.com Accessed February 20, 2000b.

  • Rindone JP, Hiller D, Collacott E, Nordhaugen N, Arriola G. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West J Med 2000; 172: 91–4.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. Clin Invest 1995; 96: 132–40.

    Article  CAS  Google Scholar 

  • Runkel DR, Cupp MJ. Glucosamine sulfate use in osteoarthritis. Am J Health Syst Pharm 1999; 56: 267–9.

    PubMed  CAS  Google Scholar 

  • Setnikar I, Giacchetti C, Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung 1986; 36: 729–35.

    PubMed  CAS  Google Scholar 

  • Setnikar I, Palumbo R, Canali S, Zanolo G. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993; 43: 1109–13.

    PubMed  CAS  Google Scholar 

  • Talent JM, Gracy RW. Pilot study of oral polymeric N-acetyl-D-glucosamine as a potential treatment for patients with osteoarthritis. Clin Ther 1996; 18: 1184–90.

    Article  PubMed  CAS  Google Scholar 

  • Thie NMR, Prasad NG, Major PW. Evaluation of glucosamine sulfate compared with ibuprofen for the treatment of temporomandibular joint osteoarthritis: a randomized double blind controlled 3 month trial. J Rheumatol 2001; 28: 1347–55.

    PubMed  CAS  Google Scholar 

  • Towheed TE, Hochberg MC. A systematic review of randomized controlled trials of pharmacologic therapy in osteoarthritis of the hip. J Rheumatol 1997; 24: 349–57.

    PubMed  CAS  Google Scholar 

  • Uebelhart D, Thonar EJMA, Delmas PD, et al. E. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 1998; 6 (suppl A): 39–46.

    Google Scholar 

  • Vaz AL. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in outpatients. Curr Med Res Opin 1982; 8: 145–9.

    Article  Google Scholar 

  • Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis Cartilage 1998; 6 (suppl A): 37–8.

    Article  PubMed  Google Scholar 

  • Volpi N. Hyaluronic acid and chondroitin sulfate unsaturated disaccharides analysis by high-performance liquid chromatography and fluorimetric detection with dansylhydrazine. Anal Biochem 2000; 277: 19–24.

    Article  PubMed  CAS  Google Scholar 

  • Wood KM, Curtis CG, Powell GM, Wusteman FS. The metabolic fate of intravenously injected peptide-bound chondroitin sulphate in the rat. Biochem J 1976; 158: 39–46.

    PubMed  CAS  PubMed Central  Google Scholar 

Download references

Authors
  1. Melanie Johns Cupp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timothy S. Tracy
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. West Virginia University, Morgantown, WV, USA

    Melanie Johns Cupp PharmD, BCPS  & Timothy S. Tracy PhD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cupp, M.J., Tracy, T.S. (2003). Glucosamine and Chondroitin. In: Cupp, M.J., Tracy, T.S. (eds) Dietary Supplements. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-303-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-303-3_13

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9726-7

  • Online ISBN: 978-1-59259-303-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation